Certara, Inc.

Certara, Inc. provides technology-driven services and software products for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access. Its portfolio includes model-informed drug development solutions such as the Simcyp simulator, a mechanistic biosimulation platform for physiologically based pharmacokinetic simulation, and Phoenix WinNonlin for non-compartmental analysis. It also offers Phoenix NLME for population modeling, Pirana Modeling Workbench, Chemaxon JChem engines for chemical searching, and Pinnacle 21 for clinical data automation. These tools help pharmaceutical companies predict pharmacokinetics and pharmacodynamics, streamline lead optimization, and support regulatory submissions.

Certara, Inc. is listed on the Nasdaq Global Select Market (NasdaqGS) under the ticker symbol CERT. Its shares are traded in United States Dollars (USD), as the company is based in the United States. The exchange is a major US stock exchange, providing liquidity and visibility for investors.

Certara operates in the Healthcare sector, specifically within the Health Information Services industry. This industry focuses on providing technology and data solutions to healthcare organizations. Certara's biosimulation software and services support drug development and regulatory processes, making it a key player in health information technology for the pharmaceutical and biotech sectors.

Certara serves clients across the Americas, Europe, the Middle East, Africa, and Asia Pacific. Its global reach allows it to support drug development and regulatory submissions worldwide. The company's solutions are used by pharmaceutical and biotechnology firms in these regions to optimize drug discovery, preclinical and clinical research, and market access strategies.

Certara's portfolio includes several notable products for biosimulation and drug development. The Simcyp simulator is a mechanistic platform for physiologically based pharmacokinetic simulation, with specialized versions like Simcyp Discovery for pre-IND stages and Simcyp Biopharmaceutics for formulation scientists. Phoenix WinNonlin is a leading platform for non-compartmental analysis, while Phoenix NLME handles population modeling. Other tools include Pirana Modeling Workbench, Chemaxon JChem engines for chemical search, Chemaxon Compound Registration for lead optimization, Chemaxon Design Hub, Certara D360 scientific informatics, and Pinnacle 21 for clinical data automation.